Jansen, Linus G.
Shah, Payal
Wabbels, Bettina
Holz, Frank G.
Finger, Robert P.
Wintergerst, Maximilian W. M.
Funding for this research was provided by:
German Ophthalmic Society
Else Kroener-Fresenius Foundation and the German Scholars Organization (EKFS/GSO 16)
BONFOR GEROK Program, Faculty of Medicine, University of Bonn (O-137.0028)
Universitätsklinikum Bonn
Article History
Received: 3 January 2021
Accepted: 31 May 2021
First Online: 16 June 2021
Competing interests
: Linus G. Jansen: funding by German Ophthalmic Society (doctoral scholarship); Payal Shah: no conflicts of interest and no funding to report; Bettina Wabbels: Research Grant Support: Allergan, Merz; Travel fees and honoraria: Desitin, Merz, Santhera; Frank G. Holz: Research Grant Support: Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, CenterVue, Ellex, Roche/Genentech, Geuder, Kanghong, NightStarx, Novartis, Optos, Zeiss; Consultant: Acucela, Aerie, Allergan, Apellis, Bayer, Boehringer-Ingelheim, ivericbio, Roche/Genentech, Geuder, Grayburg Vision, ivericbio, LinBioscience, Kanghong, Novartis, Pixium Vision, Oxurion, Stealth BioTherapeutics, Zeiss; Robert P. Finger: funding was provided by Else Kroener-Fresenius Foundation and the German Scholars Organization (EKFS/GSO 16); financial support: Novartis, Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue. Consultant: Bayer, Novartis, Roche/Genentech, Boehringer-Ingelheim, Opthea, Santhera, Inositec, Alimera, Allergan, Ellex; Maximilian W.M. Wintergerst: Funding was provided by the BONFOR GEROK Program, Faculty of Medicine, University of Bonn, (Grant No O-137.0028); DigiSight Technologies: travel grant, D-EYE Srl: imaging devices, Heine Optotechnik GmbH: research funding, imaging devices, travel reimbursements, consultant; Eyenuk, Inc: free trial analysis; ASKIN & CO GmbH: travel reimbursement, honoraria; Berlin-Chemie AG: grant, travel reimbursements; Imaging devices were provided by Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue.